During the past decade, National Hospital Organization Sagamihara National Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Sagamihara National Hospital" #1 sponsor was "Pfizer" with 7 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Sagamihara National Hospital" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Tokyo Medical and Dental University" with 1 trials as a collaborator and "Yokohama City University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Sagamihara National Hospital" are "Rheumatoid Arthritis" (5 trials), "Psoriasis" (2 trials), "Urothelial Cancer" (2 trials), "Atopic Dermatitis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "National Hospital Organization Sagamihara National Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Sagamihara National Hospital" are "Drug" (14 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "CP-690,550" (2 trials), "Spesolimab" (2 trials), "Apremilast" (1 trials) and "Archival Tumor Tissue Sample" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Sagamihara National Hospital" are 17 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Sagamihara National Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in National Hospital Organization Sagamihara National Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Sagamihara National Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".